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Understanding the α-crystallin
-crystallin cell membrane conjunction
Abstract
PURPOSE. It is well established that levels of soluble α-crystallin in the lens cytoplasm fall steadily with
age, accompanied by a corresponding increase in the amount of membrane-bound α-crystallin. Less well
understood, is the mechanism driving this age-dependent membrane association. The aim of this study
was to investigate the role of the membrane and its associated proteins and peptides in the binding of αcrystallin.
METHODS. Fibre cell membranes from human and bovine lenses were separated from soluble proteins by
centrifugation. Membranes were stripped of associated proteins with successive aqueous, urea and
alkaline solutions. Protein constituents of the respective membrane isolates were examined by SDS-PAGE
and Western immunoblotting. Recombinant αA- and αB-crystallins were fluorescently-labeled with
Alexa350® dye and incubated with the membrane isolates and the binding capacity of membrane for αcrystallin was determined.
RESULTS. The binding capacity of human membranes was consistently higher than that of bovine
membranes. Urea- and alkali-treated membranes from the nucleus had similar binding capacities for αAcrystallin, which were significantly higher than both cortical membrane extracts. αB-Crystallin also had a
higher affinity for nuclear membrane. However, urea-treated nuclear membrane had three times the
binding capacity for αB-crystallin as compared to the alkali-treated nuclear membrane. Modulation of the
membrane-crystallin interaction was achieved by the inclusion of an N-terminal peptide of αB-crystallin in
the assays, which significantly increased the binding. Remarkably, following extraction with alkali, full
length αA- and αB-crystallins were found to remain associated with both bovine and human lens
membranes.
CONCLUSIONS. Fiber cell membrane isolated from the lens has an inherent capacity to bind α-crystallin.
For αB-crystallin, this binding was found to be proportional to the level of extrinsic membrane proteins in
cells isolated from the lens nucleus, indicating these proteins may play a role in the recruitment of αBcrystallin. No such relationship was evident for αA-crystallin in the nucleus, or for cortical membrane
binding. Intrinsic lens peptides, which increase in abundance with age, may also function to modulate the
interaction between soluble α-crystallin and the membrane. In addition, the tight association between αcrystallin and the lens membrane suggests that the protein may be an intrinsic component of the
membrane structure.

Keywords
CMMB

Disciplines
Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences

Publication Details
Su, S., McArthur, J. D., Friedrich, M. G., Truscott, R. J. W. and Aquilina, J. Andrew. (2011). Understanding
the a-crystallin cell membrane conjunction. Molecular Vision, 17 2798-2807.

This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/1276

Title of Paper:
Understanding the α-crystallin cell membrane conjunction
Authors:
Shih-Ping Su1, 2, Jason D. McArthur1, Michael G. Friedrich2, Roger J.W. Truscott2 and J. Andrew
Aquilina1
Institutes:
1
2

School of Biological Sciences, University of Wollongong, Wollongong, NSW, Australia 2522
Save Sight Institute, University of Sydney, GPO Box 4337, Sydney, NSW, Australia 2001

Corresponding Authors:
J. Andrew Aquilina
School of Biological Sciences, University of Wollongong, Wollongong, NSW, Australia 2522
aquilina@uow.edu.au
Roger J.W. Truscott
Save Sight Institute, University of Sydney, GPO Box 4337, Sydney, NSW, Australia 2001
rjwt@eye.usyd.edu.au
Email Addresses of Authors:
Shih-Ping Su, sps55@uowmail.edu.au; Jason McArthur, jasonm@uow.edu.au; Roger Truscott,
rjwt@eye.usyd.edu.au; Andrew Aquilina, aquilina@uow.edu.au

Abstract
PURPOSE. It is well established that levels of soluble α-crystallin in the lens cytoplasm fall steadily
with age, accompanied by a corresponding increase in the amount of membrane-bound α-crystallin.
Less well understood, is the mechanism driving this age-dependent membrane association. The aim
of this study was to investigate the role of the membrane and its associated proteins and peptides in
the binding of α-crystallin.
METHODS. Fibre cell membranes from human and bovine lenses were separated from soluble
proteins by centrifugation. Membranes were stripped of associated proteins with successive aqueous,
urea and alkaline solutions. Protein constituents of the respective membrane isolates were examined
by SDS-PAGE and Western immunoblotting. Recombinant αA- and αB-crystallins were
fluorescently-labeled with Alexa350® dye and incubated with the membrane isolates and the
binding capacity of membrane for α-crystallin was determined.
RESULTS. The binding capacity of human membranes was consistently higher than that of bovine
membranes. Urea- and alkali-treated membranes from the nucleus had similar binding capacities for
αA-crystallin, which were significantly higher than both cortical membrane extracts. αB-Crystallin
also had a higher affinity for nuclear membrane. However, urea-treated nuclear membrane had three
times the binding capacity for αB-crystallin as compared to the alkali-treated nuclear membrane.
Modulation of the membrane-crystallin interaction was achieved by the inclusion of an N-terminal
peptide of αB-crystallin in the assays, which significantly increased the binding. Remarkably,
following extraction with alkali, full length αA- and αB-crystallins were found to remain associated
with both bovine and human lens membranes.
CONCLUSIONS. Fiber cell membrane isolated from the lens has an inherent capacity to bind
α-crystallin. For αB-crystallin, this binding was found to be proportional to the level of extrinsic
membrane proteins in cells isolated from the lens nucleus, indicating these proteins may play a role
in the recruitment of αB-crystallin. No such relationship was evident for αA-crystallin in the
nucleus, or for cortical membrane binding. Intrinsic lens peptides, which increase in abundance with
age, may also function to modulate the interaction between soluble α-crystallin and the membrane.
In addition, the tight association between α-crystallin and the lens membrane suggests that the
protein may be an intrinsic component of the membrane structure.

Introduction
The human lens grows continuously throughout life via the addition of new fibre cells on top of
preexisting ones. This process leads to the formation of two lens regions referred to as the nucleus,
consisting of fibre cells formed in utero, and an ever-expanding cortex which consists of fibre cells
formed post-natally [1, 2]. Lens fibre cells contain a high concentration of the structural proteins α-,
β- and γ-crystallins, which contribute significantly to the transparent and refractive properties of the
lens. α-Crystallin, which is composed of subunits αA and αB, functions additionally as a molecular
chaperone [3, 4]. As there is little to no protein turnover in mature lens fibre cells [5], the long-term
transparency of the lens is dependent on the ability of α-crystallin to sequester unfolded proteins and
maintain them in soluble chaperone-client complexes.
Lens proteins undergo a multitude of posttranslational modifications during aging, which over time
contribute to the unfolding and denaturation of crystallins [6-12]. With age, the level of unfolded
proteins eventually exceeds the chaperone capacity of α-crystallin in the lens, such that by 40 years,
all free α-crystallin in the lens has been utilized [13-15]. Subsequently, the level of water-insoluble
and high molecular weight crystallin aggregates in the lens increases significantly [16-19].
Large-scale binding of α-crystallin to lens membranes has also been documented in the lens with age
[20-22], and this has been hypothesized to contribute to the development of nuclear cataract by
occluding membrane pores, thus leading to the formation of a barrier to diffusion [22-24].
The association between crystallins and lens fibre cell membranes is believed to be an important
process by which crystallin insolubilization occurs in the aging lens [22, 25, 26]. Chandrasekher and
Cenedella [25] showed that essentially all water-insoluble crystallins in old human lenses are
membrane-bound. α-Crystallin, in particular, has a strong affinity towards lens membrane [20, 21,
27-30], leading to the suggestion that the overall increase in the membrane binding of crystallins in
the lens is due to other crystallins associating with membrane-bound α-crystallin [27]. However, little
is currently known about the mechanism(s) by which α-crystallin associates with the cellular
membrane, and how age-related changes to the membrane compositions may affect
crystallin-binding.
In this study, we examined the protein constituents of bovine and human lens membranes after
successive removal of extrinsic protein. We report the effects of residual membrane-associated
proteins on the binding behavior of recombinant α-crystallin and the effect upon this binding of a
known intrinsic lens peptide.

Methods
Isolation of bovine and human lens fibre cell membranes
A total of 142 human lenses, aged between 54-84 years, were obtained from donors at the Lions New
South Wales Eye Bank (Sydney, Australia). Tissue was handled in accordance with the tenets of the
Declaration of Helsinki. Fresh bovine lenses were obtained from a local abattoir. All lenses were
stored at -80 °C prior to dissection.
Lenses were separated into cortical and nuclear regions using a 4.5 mm diameter trephine. A cold
scalpel was used to remove 1 mm of tissue from each end of the resulting cylindrical center (nucleus).
The cortical and nuclear tissues from human lenses and the cortical tissues from the bovine lenses
were used in this study. Lens membranes were obtained using methods published by Russell et al. [31]
with minor modifications. Briefly, lens tissues were homogenized in 7 times (w/w) of buffer A (50
mM Tris-HCl, 5 mM EDTA, 10 mM β-mercaptoethanol, 0.2% sodium azide, pH 7.4) and incubated
at room temperature for 10 minutes. The homogenate was centrifuged at 15000 × g for 20 minutes at
4 °C, and the supernatant was discarded. The pellet was re-homogenized in buffer A and centrifuged
at 15000 × g for another 20 minutes. The resulting pellet was washed with water (MilliQTM),
centrifuged and re-homogenized in buffer B (50 mM Tris-HCl, 7 M urea, pH 7.4). The urea
concentration in the homogenate was diluted to 3.5 M with water and the homogenate was
centrifuged at 15000 × g for 20 minutes. This extraction procedure using buffer B was repeated and
the resulting pellet was washed three times with water to give the urea-treated membrane. To obtain
the alkali-treated membrane, a portion of the urea-treated membrane pellet was re-homogenized in
solution containing 0.1 M NaOH, 1 mM β-mercaptoethanol. The homogenate was incubated on ice
for 15 minutes and then centrifuged at 15000 × g for 20 minutes at 4 °C. The pellet was further
washed with 5 mM phosphate (pH 8.0), followed by two washes with water.
Isolated membranes were re-suspended in binding buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, 1.4 mM K2HPO4, 5 mM MgCl2, pH 7.3). Quantification of membrane samples was
achieved by weighing freeze-dried aliquots of the membrane suspension using an Excellence XS105
dual-range analytical balance (Mettler Toledo, Switzerland). The concentration of membrane tissue
(mg/ml) in the suspension was calculated by averaging at least four separate aliquots. Light
absorbance of membrane samples at different wavelengths (220-850 nm) was measured using a
POLARstar Omega multifunction microplate reader (BMG Labtech, Offenburg, Germany).
SDS-PAGE and Western immunoblot analysis of bovine and human lens membranes
Proteins in the bovine and human lens membrane preparations were examined using SDS-PAGE and
Western immunoblots. Samples were homogenized in SDS-PAGE loading buffer (60 mM Tris-HCl,
1% SDS, 1% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue, pH 6.8) and incubated at

room temperature for 2 h prior to loading onto 12% SDS-PAGE gels. Heating of the sample was
avoided as elevated temperatures can damage the structure of intrinsic membrane proteins [31]. All
SDS-PAGE gels were stained with Coomassie Blue R (Sigma-Aldrich, St. Louis, Missouri, USA).
For Western immunoblot analysis, antibodies which specifically recognize human and bovine filensin,
phakinin, αA- and αB-crystallins were used and were diluted to their working concentrations using
PBS/T (137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1.8 mM KH2PO4, 0.05% (v/v) Tween 20,
pH 7.4) containing 0.5% (w/v) skim milk powder. Proteins separated by SDS-PAGE were transferred
onto polyvinylidene fluoride membranes at 30 V overnight at 4 °C using the Mini Trans-Blot system
(Bio-Rad, Hercules, California, USA). Membranes were blocked for 1 h at room temperature in
PBS/T containing 5% (w/v) skim milk powder. After three 10 min washes with PBS/T, the
membranes were incubated with either a 1:1000 dilution of polyclonal anti-αA-crystallin antibody
(ab69552, Abcam, Cambridge, Massachusetts, USA), a 1:1000 dilution of polyclonal
anti-αB-crystallin antibody (ab13497, Abcam), a 1:1500 dilution of monoclonal anti-filensin
antibody (F1043, Sigma-Aldrich), or a 1:5000 dilution of monoclonal anti-vimentin antibody (V6389,
Sigma-Aldrich) for 90 min at room temperature. Following another three 10 min washes with PBS/T,
the membranes were incubated for 1 h with a 1:1500 dilution of anti-rabbit immunoglobulin G (IgG)
horseradish peroxidase (HRP) conjugate (65-6120, Invitrogen, Carlsbad, California, USA) for
anti-αA-crystallin and anti-αB-crystallin blots, or a 1:2500 dilution of goat anti-mouse IgG HRP
conjugate (SAB-100J, Stressgen, Ann Arbor, Michigan, USA) for anti-filensin and anti-vimentin
blots. Excess secondary antibodies were removed by three 10 min washes with PBS/T, and the blots
were developed in 100 mM Tris-HCl (pH 7.6) containing 1.4 mM diaminobenzidine and 0.015% (v/v)
hydrogen peroxide.
Quantification of phospholipids
Phospholipids were quantified by mass spectrometry as described previously [32]. To identify each
phospholipid, a combination of precursor and neutral loss scans were used to detect the head-group of
each phospholipid class [33]. Each phospholipid class was quantified by comparing their peak areas
with the appropriate internal standard after correction for isotope contributions [32]. The percentage
of each phospholipid was than determined by its contribution to the total phospholipid.
Overexpression and purification of recombinant human αA- and αB-crystallins
The pET23d(+) plasmid, containing human wild-type αA-crystallin gene, was a gift from Prof. J. M.
Petrash (Washington University, St. Louis, USA). The pET24d(+) plasmid (Novagen, Madison,
Wisconsin, USA), containing human wild-type αB-crystallin gene, was a gift from Prof. W. de Jong
(University of Nijmegen, Nijmegen, The Netherlands). Plasmids were transformed into
electro-competent Escherichia coli BL21 cells by electroporation using a GenePulser II system
(Bio-Rad). 900 mL of LB stocks (1% tryptone, 0.5% yeast extract, 1% NaCl) that contained
ampicillin (100 µg/mL) or kanamycin (50 µg/mL) were inoculated with 100 mL of overnight liquid

cultures of BL21/pET23d-αA or BL21/pET24d-αB cells, respectively, and grown at 37 °C under
vigorous shaking. The culture was induced with 10 mL of 50 mM isopropyl
β-D-1-thiogalactopyranoside after reaching an optical density of ~0.5 at 600 nm, and further
incubated for 3 h at 37 °C. Cells were harvested by centrifugation, and the expressed proteins were
isolated using methods by Horwitz et al. [34]. Recombinant human αA and αB-crystallin were
purified from the cell lysates using anion-exchange chromatography (HiPrep 16/10 DEAE FF
column; GE Healthcare, Little Chalfont, United Kingdom), followed by size-exclusion
chromatography (HiPrep 26/60 Sephacryl S-300 column; Amersham Biosciences, Uppsala, Sweden).
Conjugation of Alexa350® to α-crystallin subunits
Alexa350® fluorescent tag (410 Da) was conjugated to recombinant αA- and αB-crystallins using an
Alexa Fluor® 350 Protein Labeling Kit (A10170, Molecular Probes, Carlsbad, California, USA), in
accordance with the manufacturer’s instructions. Purified Alexa350®-conjugated αA- and
αB-crystallins were measured using absorbance readings at 280 nm and 346 nm (A280 and A346) on a
UVmini-1240 UV-VIS spectrophotometer (Shimadzu, Kyoto, Japan). The protein concentration and
the degree of binding were determined using the following equations:

[protein] =

A280 - (A346 × 0.19)
× dilution
∈protein

(Eq. 1)

mol of dye/mol of subunit =

A346 - dilution
19000 × [protein]

(Eq. 2)
Where 0.19 is a correction factor to account for absorption of Alexa350® at 280 nm, 19000 is the
molar extinction coefficient for Alexa350® and ∈protein is the molar extinction coefficient for
α-crystallin.
Membrane binding measurements
Alexa350®-conjugated αA- and αB-crystallins were incubated with bovine and human lens
membranes in binding buffer at 37 °C for 6 h, based on protocols established previously [30]. Control
assays were set up by replacing Alexa350®-α-crystallin subunits with unlabeled α-crystallin subunits.
All assays were performed in triplicate. After incubation, samples were centrifuged at 14000 × g for
30 minutes at 4 °C. The pellets were re-suspended in 30 μL of binding buffer and centrifuged again at
14000 × g for 30 minutes at 4 °C. The supernatants from both centrifugations were pooled together.
The resulting pellets, which contained the membrane, and bound Alexa350®-α-crystallin subunits,
were re-suspended in a volume of binding buffer equivalent to that of the combined supernatants.

Both the supernatants and the re-suspended pellets were transferred to 96-well polypropylene black
microplates (Greiner Bio-One, Frickenhausen, Germany), and the fluorescence reading (F) of the
samples was measured using a FLUOstar Optima multifunction microplate reader (BMG Labtech).
The excitation and emission filters were set at 320-340 and 430-450 nm respectively. The degree of
binding ( ) was determined by the following formula, where background fluorescence readings were
obtained from control assays (using unlabeled α-crystallin):

=

Fpellet – Fpellet background
(Fpellet – Fpellet background) + (Fsupernatant – Fsuperntant background)

(Eq. 3)
The amount of α-crystallin subunits bound to the membranes was calculated by multiplying the total
mass of Alexa350®-α-crystallin subunits used in the assay by the degree of binding ( ).
Effect of endogenous crystallin peptides on the membrane binding of α-crystallin
Peptide αB1-18 (Ac-MDIAIHHPWIRRPFFPFH) was purchased from Biomatik (Cambridge, Ontario,
Canada) with sample purity ≥ 95%. Peptide γS167-178 (SPAVQSFRRIVE) was purchased from
Peptide 2.0 (Chantilly, Virginia, USA) with sample purity of ≥ 91%. Peptides were solubilised in
binding buffer to give a 4 g/L stock solution. Peptides were drawn from the stock solution and
incubated with human lens membranes (80 μg) for 30 min at 37 °C. These were then incubated for 6 h
at 37 °C in the presence of 24 μg of Alexa350®-conjugated αA- or αB-crystallin, or 24 μg of
unlabeled αA- or αB-crystallin as negative controls. Binding assays were carried out as described
previously. Peptide interaction data were analyzed using unpaired two-sample t-test.

Results
Analysis of proteins associated with lens fibre cell membranes
Bovine lens membranes
SDS-PAGE analysis of the urea-treated bovine (BU) membrane (Figure 1) showed that multiple
proteins, ranging from 10 kDa to above 200 kDa, remain bound to the bovine lens membrane after the
combined extractions of Tris- and urea-containing buffers. α-Crystallin subunits A and B (~20 kDa)
were the predominant species detected, as shown by Western immunoblots (Figure 1). In contrast,
the alkali-treated bovine (BA) lens membrane extract contained no protein that could be detected by
Coomassie staining.
Western immunoblots (Figure 1) revealed that both αA- and αB-crystallins (both ~20 kDa) were
present in the BU and BA lens membranes, with a significant amount of higher molecular weight
immuno-reactive protein also detected in the BU. Following further treatment of the membranes
with alkali, α-crystallin subunits and a ~50 kDa αA species of protein remained (Figure 1). Of the
two major intermediate filament proteins of the lens fibre cell cytoskeleton, intact filensin (115 kDa)
and multiple cleavage products of filensin were detected only in the BU membrane, while vimentin
(54 kDa) was present in both bovine lens membrane preparations (Figure 1).
Human lens membranes
SDS-PAGE analysis (Figure 2) revealed human lens membrane to be very different from bovine
lens membrane. Three proteins of ~20 kDa, 22 kDa and 26 kDa, which correspond to
αA/αB-crystallin, major intrinsic protein (MIP) 22 and MIP26 respectively, were present in all
human lens membrane preparations (Figure 2). The urea-treated membrane preparations,
particularly urea-treated nucleus (NU) membrane, showed noticeable smearing down the length of
the gel. In addition, a low molecular weight (LMW) band which migrated with the dye-front was
observed, which was particularly intense in the urea extracts. The presence of this band indicates that
significant amounts of LMW peptides, likely derived from crystallins [35-37], remain tightly
associated with the lens membranes after extraction with urea.
Western immunoblots detected intact αA- and αB-crystallins (~20 kDa) in all human lens
membrane preparations, even after the membranes had been stripped of the majority of extrinsic
proteins with strong alkali solution (Figure 2). A diffuse band at ~43 kDa was also present in each of
the αA-crystallin blots, with additional smearing between 70 kDa and 130 kDa, being particularly
noticeable in the alkali-treated nuclear (NA) preparation. On the anti-αB-crystallin blots, extensive
smearing was observed in the lanes of the urea-treated membranes, some of which may be
attributed to non-specific immunoreactivity as described above. Interestingly, a variety of smaller
αB-crystallin products less than 20 kDa remained bound to the lens membrane after urea-treatment
(Figure 2). Most of the anti-αB reactive proteins were removed upon treatment with 0.1 M NaOH,

except for some intense smearing from 90-150 kDa. Smearing was also observed on the anti-filensin
blots of the urea-treated human lens membrane, while no filensin was detected in the alkali-treated
membranes (Figure 2). Vimentin was only detected in the cortical human lens membrane preparations
(Figure 2).
Binding of α-crystallin subunits to lens membranes

Purification of Alexa350®-α-crystallin subunits
Recombinant human αA- and αB-crystallins were over-expressed in E. coli and conjugated to
Alexa350®. On average, 0.56 ± 0.07 mol of Alexa350® was attached per mol of αA-crystallin, and
0.44 ± 0.36 mol of Alexa350® per mol of αB-crystallin.

Bovine lens membrane binding
In order to compare the binding of α-crystallins to bovine and human lens membranes, we pre-labeled
recombinant αA- and αB-crystallins with Alexa350®, whose excitation and emission characteristics
are spectrally distinct from aromatic amino acids. Binding assays using BU and BA membranes
displayed saturable binding behavior (Figure 3), which allowed us to calculate the membrane
binding capacity from the asymptote of each curve (Table 1). The binding capacities for
αA-crystallin were 28.1 ± 2.4 ng αA/μg BU membrane, and 19.5 ± 0.8 ng αA/μg BA membrane.
The binding capacities for αB-crystallin were lower, being 19.1 ± 1.1 ng αB/μg BU membrane and
6.0 ± 0.6 ng αB/μg BA membrane.

Human lens membrane binding
All of the assays using human lens membranes displayed saturable binding of the
Alexa350-α-crystallins (Figure 4), and the binding capacity was greater, on the whole, than bovine
lens membranes (Table 1). Comparing regions, a matched treatment analysis revealed that nuclear
membrane had significantly greater binding capacity for the α-crystallins than cortical membrane
(P<0.05). Matched region analysis indicated the difference in binding due to solvent treatment is
less significant (P>0.1). For example, αA-crystallin was observed to bind NU and NA membrane
with less than 20% difference in capacity, while CU and CA displayed almost identical
αA-crystallin binding capacity. αB-Crystallin, however, exhibited significantly greater binding to
the NU membrane than the NA membrane (208.0 ± 13.1 ng /μg compared with 67.0 ± 2.4 ng /μg).
This result strongly suggests that proteins removed from the nuclear membrane by the alkali
treatment have a much higher affinity for αB-crystallin than the extrinsic proteins of the cortex
membrane.

Membrane lipid analysis revealed no significant alteration in the ratios of the eight major classes
(dihydrosphingomyelin, sphingomyelin, phosphatidylcholine, phosphatidylserine, ceramide,
dihydroceramide, phosphatidylethanolamine and lysophosphatidylethanolamine) between the
human membrane preparations used in these binding assays (Figure A1, Appendix I), demonstrating
that membrane binding of α-crystallin was not influenced by changes to the proportion of individual
membrane lipids. Human membrane preparations displayed no significant absorbance between
380-500 nm (Figure A2, Appendix II), indicating there would be minimal interference with the
fluorescent signal emitted by the Alexa350® dye.
Effect of crystallin peptides on the membrane binding of α-crystallin subunits
In a recent study, we reported that crystallin peptides αB1-18 and γS167-178 were present in human
lenses across a broad age-range [36]. Santhoshkumar et al. [35] reported that peptide αB1-18 possessed
anti-chaperone activity against α-crystallin, while peptide γS167-178 had little effect. Peptide αB1-18
was found to significantly increase the amount of membrane-bound α-crystallin subunits in all but
the CU membranes (Figure 5). In the case of αA-crystallin, the addition of peptide αB1-18 increased
the binding by 59% (NU membrane), 72% (CA membrane) and 72% (NA membrane). Similar
results were observed in binding assays using αB-crystallin, with the amount of membrane-bound
αB-crystallin increasing by 61% (CA membrane) and 69% (NA membrane). However, peptide
αB1-18 did not give rise to a significant increase in binding of αB-crystallin to the urea-treated
membranes (Figure 5B), possibly due to the amount of endogenous αB-crystallin that is present on
this membrane preparation (Figure 2). The addition of peptide γS167-178 had a negligible effect on the
binding of both αA- and αB-crystallins to all human lens membrane preparations (Figure 5).

Discussion
There is growing evidence that association with fibre cell membranes is an important process by
which crystallins become water-insoluble in the lens [22, 25, 30]. This association may also
contribute to the age-dependent loss of free α-crystallin [13-15]. In addition, large-scale binding of
crystallin aggregates after middle age [22, 23] is implicated in the development of the lens barrier – a
significant event in the human lens that is associated with subsequent cataractogenesis [24, 38, 39].
Building upon previous studies, where the membrane binding of α-crystallin was characterized using
non-human lens tissues [26, 30, 40-44], here we determined the binding properties of α-crystallin to
membranes isolated from both bovine and human lens tissues.
αA- and αB-crystallins were the dominant membrane-bound proteins in the bovine lens after
extraction with urea, whereas the human membrane also contained significant amounts of aquaporin
0 (AQP0) (MIP26, MIP22), small peptides and, particularly in the nucleus, a complex mixture of
cytoskeletal and crystallin proteins. Full-length αA- and αB-crystallins remained tightly associated
with both the bovine and human lens membranes after extraction with 7 M urea, and remarkably,
even after the alkali-treatment. The presence of α-crystallin after such vigorous treatment indicates
that it is very tightly associated with, or even partially embedded in the fibre cell membrane. To our
knowledge, this is the first evidence which suggests that α-crystallins may be an intrinsic
component of the lens fibre cell membrane. Given the important role that α-crystallin has on the
structural assembly of the beaded filaments [46, 47], the incorporation of α-crystallin into the fibre
cell membrane structure may have functional significance regarding the stability and order of the
lipid bilayer. Furthermore, fatty acid acylation, which confers membrane anchoring properties to
proteins, and has been reported for lens AQP0 [45], may also contribute to the tight association
between α-crystallin and the lens membrane, if α-crystallin subunits are acylated in a similar
manner.
We observed that the level of αB-, but not αA-crystallin, binding to the bovine and human
membranes was influenced by the extent to which the membrane had been stripped of extrinsic
proteins. This may be due to the fact that αB-crystallin is a more potent chaperone at physiological
temperatures (37-40 °C) compared to αA-crystallin[48], and that membrane-bound proteins represent
potential chaperone targets. As the alkali-treated membranes were largely stripped of this
membrane-bound protein, the interacting targets for αB-crystallin decreased significantly, thus
lower binding capacity was observed. These results suggest that the mechanisms by which αA- and
αB-crystallins associate with the cellular membrane are different; αA-crystallin may interact
exclusively with membrane phospholipids, thereby being unaffected by the presence of extrinsic
proteins on the membrane, whereas these proteins may act as conduits for αB-crystallin to bind to
the membrane.

Membrane binding of both αA- and αB-crystallins was significantly increased in the presence of
peptide αB1-18. It has previously been reported that when mixed with wild-type αB-crystallin, peptide
αB1-18 increased the oligomeric size of the protein[49]. Thus, our results may reflect the fact that
larger α-crystallin oligomers containing greater numbers of α-crystallin subunits are binding to the
membrane. Considering that the emergence of this peptide in the lens nucleus [36] corresponds to the
time when large-scale binding of α-crystallin to lens membrane is observed [22], this and other
endogenous peptides [35, 36] may play a role in this process.
Previous studies into membrane binding of α-crystallin have produced conflicting outcomes. For
example, Ifeanyi et al. [42] found that the association of α-crystallin to membranes was mainly due
to the αA subunit. In contrast, Cobb and Petrash [30] suggested that αA and αB subunits have
similar binding capacities to lens membranes. Typically, membrane binding studies were performed
using non-human lens membranes. As the membrane binding of α-crystallin is affected by the
presence of membrane-bound proteins, and endogenous peptides, the use of non-human tissue does
not appear to represent a useful model for the aging human lens.
Recent studies have also shown that the lipid composition of human lens membrane differs
considerably from that of other mammalian animals [32]. The levels of dihydrosphingomyelin and
cholesterol are much higher in human lenses [32], and these hydrophobic components [50] could
mimic the exposed hydrophobic residues on substrate proteins, with which α-crystallin is known to
interact [51, 52]. Another characteristic of the human lens is that its phospholipids undergo major
changes with age. The levels of glycerophospholipids in the nucleus of the lens decline steadily,
such that by age 40, their content is negligible [53]. In contrast, the levels of ceramides and
dihydroceramides in the lens nucleus increase approximately 100-fold during middle-age [53]. It is
therefore possible that age-related changes to membrane phospholipids are influential in the binding
of α-crystallin and the persistence of this versatile small heat-shock protein may also be an important
component of the fibre cell membrane itself.
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Figure Legends:
Figure 1: SDS-PAGE and Western immunoblot analysis of bovine lens membranes. The
water-insoluble cell membrane pellets from bovine lens homogenates washed with 7 M urea (BU)
and with 0.1 M NaOH (BA). Samples were analyzed by SDS-PAGE (100 μg of membrane per lane)
and Western immunoblotting (20 μg of membrane per lane). Blots were probed using
anti-αA-crystallin, anti-αB-crystallin, anti-filensin and anti-vimentin antibodies, as indicated.
Molecular weight markers are on the left of the figure.
Figure 2: SDS-PAGE and Western immunoblot analysis of human lens membranes. Isolated
cortical and nuclear lens membranes were extracted with 7 M urea in Tris buffer (CU – cortex urea;
NU – nucleus urea) and with 0.1 M NaOH (CA – cortex alkali; NA – nucleus alkali). Samples were
analyzed by SDS-PAGE (100 μg of membrane per lane) and with Western immunoblotting (20 μg of
membrane per lane). Blots were probed using anti-αA-crystallin, anti-αB-crystallin, anti-filensin and
anti-vimentin antibodies, as indicated. Molecular weight markers are on the left of the figure.
Figure 3: Binding of α-crystallin to bovine lens membrane preparations. Binding curves
depicting the amount of bound Alexa350®-conjugated αA- (A) and αB-crystallin (B) per μg of
urea-treated (●) or alkali-treated (▲) bovine lens membrane as a function of the free α-crystallin
concentration. Bovine lens membranes (200 μg) were incubated with a mass range of
Alexa350®-conjugated αA- and αB-crystallins, for 6 h at 37 °C. Results are the mean ± SEM (n = 3).
Figure 4: Binding of α-crystallin to human lens membrane preparations. Binding curves
depicting the amount of bound Alexa350®-conjugated αA- (A) and αB-crystallin (B) per μg of
urea-treated cortical (●) and nuclear (▲) human lens membrane, or alkali-treated cortical (○) and
nuclear (∆) human lens membrane as a function of the free α-crystallin concentration. Human lens
membranes (80 μg) were incubated with a mass range of Alexa350®-conjugated αA- and
αB-crystallins, for 6 h at 37 °C. Results are the mean ± SEM (n = 3).
Figure 5: Effect of crystallin peptides on the binding of α-crystallin to human lens membranes.
Graphs showing the amount (ng) of Alexa350®-conjugated αA- (A) or αB-crystallin (B) bound per
μg of human lens membrane in the presence of crystallin peptides. Human lens membranes (80 μg)
were mixed with either 48 μg of peptide αB1-18 (solid bars), 48 μg of peptide γS167-178 (dotted bars),
or with binding buffer only (horizontal line bars), for 30 min at 37 °C. Alexa350®-conjugated αA- or
αB-crystallin (24 μg) was then added and the mixtures were incubated for 6 h at 37 °C. Results are
the mean ± SEM (n = 3). *P<0.05, **P<0.01, ***P<0.001 compared with assays performed with
binding buffer only (horizontal line bars).

Table 1: Binding capacity of bovine and human lens membranes for Alexa350®-α-crystallin
subunits.
Membrane

αA binding capacity

αB binding capacity

samples

(ng/μg membrane)

(ng/μg membrane)

BU

28.1 ± 2.4

19.1 ± 1.1

BA

19.5 ± 0.8

6.0 ± 0.6

CU

31.5 ± 2.0

54.3 ± 4.2

CA

33.4 ± 2.8

31.6 ± 1.8

NU

95.4 ± 4.2

208.0 ± 13.1

NA

78.5 ± 2.0

67.0 ± 2.4

Abbreviations used: BU – urea-treated bovine membrane; BA – alkali-treated bovine membrane;
CU – urea-treated human cortical membrane; CA – alkali-treated human cortical membrane; NU –
urea-treated human nuclear membrane; NA – alkali-treated human nuclear membrane.

